• 1
    Paget S 1889 The distribution of secondary growths in cancer of the breast. Lancet 1:571572.
  • 2
    Chirgwin JM, Guise TA 2000 Molecular mechanisms of tumor-bone interactions in osteolytic metastases. Crit Rev Eukaryotic Gene Exp 12:159178.
  • 3
    Guise TA, Mundy GR 1998 Cancer and Bone. Endocrine Rev 19:1854.
  • 4
    Weiss L 1992 Comments on hematogenous metastatic patterns in humans as revealed by autopsy. Clin Exp Metastasis 10:191199.
  • 5
    Cifuentes N, Pickren JW 1979 Metastases from carcinoma of mammary gland: An autopsy study. J Surg Oncol 11:193205.
  • 6
    Coleman RE, Rubens RD 1987 The clinical course of bone metastases from breast cancer. Br J Cancer 55:6166.
  • 7
    Taube T, Elomaa I, Blomquist C, Beneton MNC, Ksuis JA 1994 Histomorphometric evidence for osteoclast-mediated bone resorption in metastatic breast cancer. Bone 15:161166.
  • 8
    Boyde A, Maconnachie E, Reid SA, Delling G, Mundy GR 1986 Scanning electron microscopy in bone pathology: Review of methods. Potential and applications. Scanning Electron Microsc 4:1537.
  • 9
    Francini G, Petrioloi R, Maioli E, Gonnelli S, Marsili S, Aquino A, Bruni S 1993 Hypercalcemia in breast cancer. Clin Exp Metastasis 11:359367.
  • 10
    Clohisy DR, Palkert D, Rammaraine MGR, Pekurovsky I, Oorsler MJ 1996 Human breast cancer induces osteoclast activation and increases the number of osteoclasts at sites of tumor osteolysis. J Orthop Res 14:396402.
  • 11
    Sasaki A, Boyce BF, Story B, Wright KR, Chapman M, Boyce R, Mundy GR, Yoneda T 1995 The bisphosphonate risedronate reduces metastatic human breast cancer burden in bone in nude mice. Cancer Res 55:35513557.
  • 12
    Wysolmerski JJ, Broadus AE 1994 Hypercalcemia of malignancy: The central role of parathyroid hormone related protein. Annu Rev Med 45:189200.
  • 13
    Strewler GJ 2000 The physiology of parathyroid hormone-related protein. N Engl J Med 342:177185.
  • 14
    Isales C, Carcangiu ML, Stewart AF 1987 Hypercalcemia in breast cancer: Reassessment of the mechanism. Am J Med 82:11431146.
  • 15
    Wysolmerski JJ, McCaughern-Carucci JF, Daifotis AG, Broadus AE, Philbrick WM 1996 Overexpression of parathyroid hormone-related protein or parathyroid hormone in transgenic mice impairs branching morphogenesis during mammary gland development. Development 121:35393547.
  • 16
    Wysolmerski JJ, Philbrick WM, Dunbar ME, Lanske B, Kronenberg H, Karaplis A, Broadus AE 1998 Rescue of the parathyroid hormone-related protein knockout mouse demonstrates that parathyroid hormone related protein is essential for mammary gland development. Development 125:12851294.
  • 17
    Dunbar ME, Wysolmerski JJ 1999 Parathyroid hormone-related protein: A developmental regulatory molecule necessary for mammary gland development. J Mammary Gland Biol Neoplasia 4:2134.
  • 18
    Kovacs CS, Kronenberg HM 1997 Maternal-fetal calcium and bone metabolism during pregnancy, puerperium, and lactation. Endocr Rev 18:832872.
  • 19
    Kovacs CS 2001 Calcium and bone metabolism in pregnancy and lactation. J Clin Endocrinol Metab 86:23442348.
  • 20
    Bundred NJ, Walter RA, Coley S, Morrison JJ, Ratcliffe JG 1991 Parathyroid hormone related protein and hypercalcemia in breast cancer. BMJ 303:15061509.
  • 21
    Bundred NJ, Walker RA, Ratcliffe WA, Warwick J, Morrison JM 1996 Parathyroid hormone related protein and skeletal morbidity in breast cancer. Eur J Cancer 28:690692.
  • 22
    Kohno N, Kitazawa S, Fukase M, Sakoda Y, Kanabara Y, Furuya Y, Ohashi O, Ishakawa Y, Saitoh Y 1996 The expression of parathyroid hormone-related protein in human breast cancer with skeletal metastases. Surg Today 24:215220.
  • 23
    Powell GJ, Southby J, Danks JA, Stillwell RG, Hayman JA, Henderson MA, Bennett RC, Martin TJ 1991 Localization of parathyroid hormone-related protein in breast cancer metastases: Increased incidence in bone compared with other sites. Cancer Res 51:30593061.
  • 24
    Vargas SJ, Gillespie MT, Powell GJ, Southby J, Danks JA, Moseley JM, Martin TJ 1992 Localization of parathyroid hormone-related protein mRNA expression in breast cancer and metastatic lesions by in situ hybridization. J Bone Miner Res 7:971980.
  • 25
    Yoshida A, Nakamura Y, Shimizu A, Harada M, Kameda Y, Nagano A, Inaba M, Asaga T 2000 Significance of parathyroid hormone-related protein expression in breast carcinoma. Breast Cancer 7:215220.
  • 26
    Henderson MA, Danks JA, Moseley JM, Slavin JL, Harris TL, McKinlay MR, Hopper JL, Martin TJ 2001 Parathyroid hormone-related protein production by breast cancers, improved survival and reduced bone metastases. J Natl Cancer Inst 93:234237.
  • 27
    Thomas RJ, Guise TA, Yin JJ, Elliot J, Horwood NJ, Martin TJ, Gillespie MT 1999 Breast cancer cells interact with osteoblasts to support osteoclast formation. Endocrinology 140:44514458.
  • 28
    Guise TA, Lin JJ, Taylor SD, Kumagai Y, Dallas M, Boyce B, Yoneda T, Mundy GR 1996 Evidence for a causal role of parathyroid hormone-related protein in the pathogenesis of human breast cancer-mediated osteolysis. J Clin Invest 98:15441549.
  • 29
    Foley J, Dann P, Hong J, Cosgrove J, Dreyer B, Rimm D, Dunbar ME, Philbrick W, Wysolmerski JJ 2001 Parathyroid hormone-related protein maintains mammary epithelial fate and triggers nipple skin differentiation during embryonic mammary development. Development 128:513525.
  • 30
    Bonser GM 1954 Evolution of mammary cancer induced in virgin female IF mice with minimal doses of locally acting methylcholanthrene. J Pathol Bacteriol 68:531546.
  • 31
    Burtis WJ, Brady TG, Orloff JJ, Ersbak JB, Warrell RP, Olson BR, Wu TL, Mitnick ME, Broadus AE, Stewart AF 1990 Immunochemical characterization of circulating parathyroid hormone-related protein in patients with humoral hypercalcemia of cancer. N Engl J Med 322:11061112.
  • 32
    Smith GH, Mehrel T, Roop DR 1988 Differential keratin gene expression in developing, differentiating, preneoplastic, and neoplastic mouse mammary epithelium. Cell Growth Differ 89:173183.
  • 33
    Russo J, Saby J, Isenberg WM, Russo IH 1977 Pathogenesis of mammary carcinomas induced in rats by 7,12-dimethylbenz[a]antracene. J Natl Cancer Inst 59:435445.
  • 34
    Moon RC 1969 Relationship between previous reproductive history and chemically induced mammary cancer in rats. Int J Cancer 4:312317.
  • 35
    Russo J, Russo IH 1999 Cellular basis of breast cancer susceptibility. Oncol Res 11:169178.
  • 36
    Falzon M, Du P 2000 Enhanced growth of MCF-7 breast cancer cells overexpressing parathyroid hormone-related peptide. Endocrinology 141:18821892.
  • 37
    Cataisson C, Lieberherr M, Cros M, Gauville C, Graulet AM, Cotton J, Calvo F, deVernejoul MC, Foley J, Bouizar Z 2000 Parathyroid hormone-related peptide stimulates proliferation of a highly tumorigenic human SV40-immortalized breast epithelial cells. J Bone Miner Res 15:21292139.
  • 38
    Yin JJ, Selander K, Chirgwin JM, Dallas M, Grubbs BG, Wieser R, Massague J, Mundy GR, Guise TA 1999 TGF-β signaling blockade inhibits PTHrP secretion by breast cancer cells and bone metastases development. J Clin Invest 103:197206.
  • 39
    Sanders JL, Chattopadhyay N, Kifor O, Yamaguchi T, Butters RR, Brown EM 2000 Extracellular calcium-sensing receptor expression and its potential role in regulating parathyroid hormone-related peptide secretion in human breast cancer cell lines. Endocrinology 141:43574364.
  • 40
    Luparello C, Santamaria F, Schilling T 2000 Regulation of PTHrP and PTH/PTHrP receptor by extracellular Ca2+ concentration and hormones in the breast cancer cell line 8701-BC. Biol Chem 381:303308.
  • 41
    Cardiff RD, Anver MR, Gusterson BA, Hennighausen L, Jensen RA, Merino MJ, Rehm S, Russo J, Tavassoli FT, Wakefield LM, Ward JM, Green JE 2000 The mammary pathology of genetically engineered mice: The consensus report and recommendations from the Annapolis meeting. Oncogene 19:968988.